TPP+-polyhydroxybenzoates are cytotoxic to various subtypes of breast cancer cells.
Cytotoxicity is not-dependent on the expression of estrogen/growth factor receptors.
Cytotoxicity appears to be triggered by a weak mitochondrial uncoupling effect.
Effects include loss of transmembrane potential and apoptosis was detected.
TPP+-polyhydroxybenzoates inhibit migration of highly metastatic cells.